CI

At a glance

ClinicalIndex Comparison Record
N/AUnknown· 10,000 target
Drug / intervention
No interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05023668
NCT05023668N/AUnknown
CompareCT.gov

China Atopic Dermatitis Registry Study: a Chinese Registry Study in Moderate-to-severe Atopic Dermatitis Patients Not Controlled by Topical Therapy

Peking University People's Hospital·observational·Posted Aug 26, 2021·Updated Aug 26, 2021

In Brief

An observational study evaluating No intervention for Dermatitis, Atopic. Targeting 10,000 participants across 1 site.

Detailed Summary

This regestry study is aimed to characterize the medical care and drug treatment under real-life conditions among Chinese patients with moderate to severe Atopic Dermatitis who are not well controlled by topical therapies.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDermatitis, Atopic
CountriesChina
Collaborators--

Timeline

N/AUnknownOverdue
20222023202420252026
First PostedAug 26, 2021
Enrollment StartJul 28, 2021
Primary CompletionOct 1, 2024
TodayJul 1, 2026
Enrollment to primary: 3.2 yearsPosted 4.8 years ago

Interventions

No interventionother

No intervention